Andrew Hagar, MD
Orthopaedic Surgery · Concord, NHNPI 1982134946
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,000 of the $11,788 with a category attached, or 67.9%. Smith+Nephew accounts for 69.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $6,603 and has fallen 96.8% since, to $213 in 2025.
Across 49 payments — averaging $240.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Omnilife Science, Inc$2K
- Zimmer Biomet$804
- Stryker$525
- Medical Device Business Services, Inc.$262
- Johnson & Johnson$89
- plus $69 from 2 others
What the payments were for
- Travel & lodging$1,59914%
- Food & beverage$2,18919%
- Education$8,00068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $8,186 |
| Omnilife Science, Inc | 13 | $1,853 |
| Zimmer Biomet | 8 | $804 |
| Stryker | 12 | $525 |
| Medical Device Business Services, Inc. | 6 | $262 |
| Johnson & Johnson | 1 | $89 |
| Bioventus LLC | 2 | $46 |
| Solventum Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNIBotics 3.0$1,701
- Oxford$314
- G7$174
- Persona$132
- TRIATHLON$129
How this compares
$11,788 in reported general payments places this provider in the 75th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 345 | $981 |
| Celecoxib | 17 | $963 |
| Diclofenac Sodium | 22 | $693 |
| Oxycodone Hcl | 37 | $327 |
| Amoxicillin | 80 | $145 |
| Methylprednisolone | 11 | $81 |
| Mupirocin | 12 | $60 |
| Cephalexin | 18 | $59 |
| Methocarbamol | 13 | $59 |
| Gabapentin | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Concord
- Kristen StupayConcord$16K
- Ross McEntarferConcord$14K
- Andrew HolteConcord$6K
- Neil DionConcord$5K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.